Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3016 AL 3030

Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy

Zhang W, Feng C, Jiang H.

Ageing Res Rev. 2021 Jan;65:101207. doi: 10.1016/j.arr.2020.101207. Epub 2020 Nov 1.

Nrf2: a dark horse in Alzheimer's disease treatment

Osama A, Zhang J, Yao J, Yao X, Fang J.

Ageing Res Rev. 2020 Dec;64:101206. doi: 10.1016/j.arr.2020.101206. Epub 2020 Nov 2.

Neuromodulation in the Treatment of Alzheimer's Disease: Current and Emerging Approaches

Pople CB, Meng Y, Li DZ, Bigioni L, Davidson B, Vecchio LM, Hamani C, Rabin JS, Lipsman N.

J Alzheimers Dis. 2020;78(4):1299-1313. doi: 10.3233/JAD-200913.

Antimicrobial therapy and the potential mechanisms in Alzheimer's disease

Song X, Chen J, Hou Z, Xie N.

Neurosci Lett. 2021 Jan 10;741:135464. doi: 10.1016/j.neulet.2020.135464. Epub 2020 Nov 6.

Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

Bautista-Aguilera ÓM, Ismaili L, Iriepa I, Diez-Iriepa D, Chabchoub F, Marco-Contelles J, Pérez M.

Chem Rec. 2021 Jan;21(1):162-174. doi: 10.1002/tcr.202000107. Epub 2020 Nov 10.

Effects of repetitive paired associative stimulation on brain plasticity and working memory in Alzheimer's disease: a pilot randomized double-blind-controlled trial

Kumar S, Zomorrodi R, Ghazala Z, Goodman MS, Blumberger DM, Daskalakis ZJ, Fischer CE, Mulsant BH, Pollock BG, Rajji TK.

Int Psychogeriatr. 2023 Mar;35(3):143-155. doi: 10.1017/S1041610220003518. Epub 2020 Nov 16.

Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases

Guo R, Li L, Su J, Li S, Duncan SE, Liu Z, Fan G.

Drug Des Devel Ther. 2020 Nov 5;14:4735-4748. doi: 10.2147/DDDT.S266911. eCollection 2020.

Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations

Zorkina Y, Abramova O, Ushakova V, Morozova A, Zubkov E, Valikhov M, Melnikov P, Majouga A, Chekhonin V.

Molecules. 2020 Nov 13;25(22):5294. doi: 10.3390/molecules25225294.

CD36 in Alzheimer's Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting

Dobri AM, Dudău M, Enciu AM, Hinescu ME.

Neuroscience. 2021 Jan 15;453:301-311. doi: 10.1016/j.neuroscience.2020.11.003. Epub 2020 Nov 17.

Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?

Saponaro F, Kim JH, Chiellini G.

Int J Mol Sci. 2020 Nov 17;21(22):8672. doi: 10.3390/ijms21228672.

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer's Disease

Calvo-Rodriguez M, Kharitonova EK, Bacskai BJ.

Cells. 2020 Nov 20;9(11):2513. doi: 10.3390/cells9112513.

What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?

Wimo A.

Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):1-4. doi: 10.1080/14737167.2021.1848551. Epub 2020 Nov 26.

Non-steroidal Anti-inflammatory Drugs as Candidates for the Prevention or Treatment of Alzheimer's Disease: Do they Still Have a Role?

Villarejo-Galende A, González-Sánchez M, Blanco-Palmero VA, Llamas-Velasco S, Benito-León J.

Curr Alzheimer Res. 2020;17(11):1013-1022. doi: 10.2174/1567205017666201127163018.

Apolipoprotein J in Alzheimer's Disease: Shedding Light on Its Role with Cell Signaling Pathway Perspective and Possible Therapeutic Approaches

Moezzi SM, Mozafari N, Fazel-Hoseini SM, Nadimi-Parashkoohi S, Abbasi H, Ashrafi H, Azadi A.

ACS Chem Neurosci. 2020 Dec 16;11(24):4060-4072. doi: 10.1021/acschemneuro.0c00637. Epub 2020 Nov 29.

New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease

Zhang F, Zhong RJ, Cheng C, Li S, Le WD.

Acta Pharmacol Sin. 2021 Sep;42(9):1382-1389. doi: 10.1038/s41401-020-00565-5. Epub 2020 Dec 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias